An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells
- PMID: 15542433
- DOI: 10.1016/j.ccr.2004.09.032
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells
Abstract
Autocrine Wnt signaling in the mouse mammary tumor virus model was the first identified mechanism of canonical pathway activation in cancer. In search of this transformation mechanism in human cancer cells, we identified breast and ovarian tumor lines with upregulation of the uncomplexed transcriptionally active form of beta-catenin without mutations afflicting downstream components. Extracellular Wnt antagonists FRP1 and DKK1 caused a dramatic downregulation of beta-catenin levels in these tumor cells associated with alteration of biological properties and increased expression of epithelial differentiation markers. Colorectal carcinoma cells with knockout of the mutant beta-catenin allele retained upregulated beta-catenin levels, which also could be inhibited by these Wnt antagonists. Together, these findings establish the involvement of autocrine Wnt signaling in human cancer cells.
Similar articles
-
Redundant expression of canonical Wnt ligands in human breast cancer cell lines.Oncol Rep. 2006 Mar;15(3):701-7. Oncol Rep. 2006. PMID: 16465433
-
The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.Oncogene. 2005 Feb 3;24(6):1098-103. doi: 10.1038/sj.onc.1208303. Oncogene. 2005. PMID: 15592505
-
The Wnt connection to tumorigenesis.Int J Dev Biol. 2004;48(5-6):477-87. doi: 10.1387/ijdb.041815jb. Int J Dev Biol. 2004. PMID: 15349822 Review.
-
The significance of the Wnt pathway in the pathology of human cancers.Pathology. 2004 Apr;36(2):120-8. doi: 10.1080/00313020410001671957. Pathology. 2004. PMID: 15203747 Review.
-
Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.Oncogene. 2002 Aug 15;21(36):5548-56. doi: 10.1038/sj.onc.1205686. Oncogene. 2002. PMID: 12165853
Cited by
-
MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.BMC Cancer. 2023 Jul 17;23(1):668. doi: 10.1186/s12885-023-11113-9. BMC Cancer. 2023. PMID: 37460940 Free PMC article.
-
Genotypes and Haplotypes in the AXIN2 and TCF7L2 Genes are Associated With Susceptibility and With Clinicopathological Characteristics in Breast Cancer Patients.Br J Biomed Sci. 2022 Jan 25;79:10211. doi: 10.3389/bjbs.2021.10211. eCollection 2022. Br J Biomed Sci. 2022. PMID: 35996498 Free PMC article.
-
Umbilical cord mesenchymal stem cells and breast cancer: a good therapeutic candidate or not? A minireview.Mol Biol Rep. 2022 Sep;49(9):9017-9022. doi: 10.1007/s11033-022-07739-w. Epub 2022 Aug 8. Mol Biol Rep. 2022. PMID: 35941415 Review.
-
The role of epigenetic modifications in drug resistance and treatment of breast cancer.Cell Mol Biol Lett. 2022 Jun 28;27(1):52. doi: 10.1186/s11658-022-00344-6. Cell Mol Biol Lett. 2022. PMID: 35764927 Free PMC article. Review.
-
Upregulation of β-catenin due to loss of miR-139 contributes to motor neuron death in amyotrophic lateral sclerosis.Stem Cell Reports. 2022 Jul 12;17(7):1650-1665. doi: 10.1016/j.stemcr.2022.05.019. Epub 2022 Jun 23. Stem Cell Reports. 2022. PMID: 35750046 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
